These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31954399)

  • 1. PET imaging of mGluR5 in Alzheimer's disease.
    Mecca AP; McDonald JW; Michalak HR; Godek TA; Harris JE; Pugh EA; Kemp EC; Chen MK; Salardini A; Nabulsi NB; Lim K; Huang Y; Carson RE; Strittmatter SM; van Dyck CH
    Alzheimers Res Ther; 2020 Jan; 12(1):15. PubMed ID: 31954399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study.
    Salardini E; O'Dell RS; Tchorz E; Nabulsi NB; Huang Y; Carson RE; van Dyck CH; Mecca AP
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [
    Mecca AP; Rogers K; Jacobs Z; McDonald JW; Michalak HR; DellaGioia N; Zhao W; Hillmer AT; Nabulsi N; Lim K; Ropchan J; Huang Y; Matuskey D; Esterlis I; Carson RE; van Dyck CH
    Neuroimage; 2021 Sep; 238():118217. PubMed ID: 34052464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer's disease: A [
    Wang J; He Y; Chen X; Huang L; Li J; You Z; Huang Q; Ren S; He K; Schibli R; Mu L; Guan Y; Guo Q; Zhao J; Xie F
    Alzheimers Res Ther; 2024 Jan; 16(1):9. PubMed ID: 38217040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Evaluation and Quantification of 18F-FPEB as a Radioligand for PET Imaging of the Metabotropic Glutamate Receptor 5.
    de Laat B; Leurquin-Sterk G; Celen S; Bormans G; Koole M; Van Laere K; Casteels C
    J Nucl Med; 2015 Dec; 56(12):1954-9. PubMed ID: 26405172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal [
    Wolters EE; Ossenkoppele R; Golla SS; Verfaillie SC; Timmers T; Visser D; Tuncel H; Coomans EM; Windhorst AD; Scheltens P; van der Flier WM; Boellaard R; van Berckel BN
    Neuroimage Clin; 2020; 25():102113. PubMed ID: 31835238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment.
    Wang J; Huang Q; He K; Li J; Guo T; Yang Y; Lin Z; Li S; Vanderlinden G; Huang Y; Van Laere K; Guan Y; Guo Q; Ni R; Li B; Xie F
    Alzheimers Dement; 2024 Jun; 20(6):3876-3888. PubMed ID: 38634334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans.
    Park E; Sullivan JM; Planeta B; Gallezot JD; Lim K; Lin SF; Ropchan J; McCarthy TJ; Ding YS; Morris ED; Williams WA; Huang Y; Carson RE
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1530-41. PubMed ID: 26044120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two PET radioligands, [
    Lohith TG; Tsujikawa T; Siméon FG; Veronese M; Zoghbi SS; Lyoo CH; Kimura Y; Morse CL; Pike VW; Fujita M; Innis RB
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2458-2470. PubMed ID: 27629098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease.
    Kang Y; Henchcliffe C; Verma A; Vallabhajosula S; He B; Kothari PJ; Pryor KO; Mozley PD
    J Neuroimaging; 2019 Jan; 29(1):97-103. PubMed ID: 30230118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic modeling and long-term test-retest reproducibility of the mGluR5 PET tracer 18F-FPEB in human brain.
    Leurquin-Sterk G; Postnov A; de Laat B; Casteels C; Celen S; Crunelle CL; Bormans G; Koole M; Van Laere K
    Synapse; 2016 Apr; 70(4):153-62. PubMed ID: 26799447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional [
    Wolters EE; Ossenkoppele R; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Golla SSV; Windhorst AD; Boellaard R; van der Flier WM; Teunissen CE; Scheltens P; van Berckel BNM
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2866-2878. PubMed ID: 32291510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the effects of ketamine on mGluR5 using [
    Holmes SE; Gallezot JD; Davis MT; DellaGioia N; Matuskey D; Nabulsi N; Krystal JH; Javitch JA; DeLorenzo C; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2020 Nov; 40(11):2254-2264. PubMed ID: 31744389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry.
    Wong DF; Waterhouse R; Kuwabara H; Kim J; Brašić JR; Chamroonrat W; Stabins M; Holt DP; Dannals RF; Hamill TG; Mozley PD
    J Nucl Med; 2013 Mar; 54(3):388-96. PubMed ID: 23404089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the Radiosynthesis of [
    Varlow C; Murrell E; Holland JP; Kassenbrock A; Shannon W; Liang SH; Vasdev N; Stephenson NA
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32098347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: An 18F-FPEB PET Study.
    Leurquin-Sterk G; Van den Stock J; Crunelle CL; de Laat B; Weerasekera A; Himmelreich U; Bormans G; Van Laere K
    J Nucl Med; 2016 Nov; 57(11):1746-1752. PubMed ID: 27283933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans.
    Sullivan JM; Lim K; Labaree D; Lin SF; McCarthy TJ; Seibyl JP; Tamagnan G; Huang Y; Carson RE; Ding YS; Morris ED
    J Cereb Blood Flow Metab; 2013 Apr; 33(4):532-41. PubMed ID: 23250105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.